The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Roche
Residual tumor volume and change in tumor volume during adjuvant therapy to predict long-term survival in AVAglio: Phase 3 newly diagnosed glioblastoma patients treated with radiation, temozolomide, and bevacizumab or placebo.
 
Benjamin M. Ellingson
Consulting or Advisory Role - Agios; Bristol-Myers Squibb; MedQIA; Roche/Genentech; Siemens
Research Funding - Roche/Genentech; Siemens
 
Josep Garcia
No Relationships to Disclose
 
Cedric Revil
Employment - Roche
Stock and Other Ownership Interests - Roche
Consulting or Advisory Role - Roche
 
Olivier L. Chinot
Honoraria - AstraZeneca; Roche
Consulting or Advisory Role - Celldex; Ipsen; Roche
Research Funding - Roche
Patents, Royalties, Other Intellectual Property - Aix Mareille University
Other Relationship - Roche
 
Wolfgang Wick
Honoraria - MSD Oncology; Prime Oncology; Roche/Genentech
Consulting or Advisory Role - Celldex; Roche/Genentech
Research Funding - Apogenix (Inst); Boehringer Ingelheim (Inst); Roche (Inst)
 
Frank Saran
Honoraria - Roche
Consulting or Advisory Role - Roche
Travel, Accommodations, Expenses - Roche
 
Ryo Nishikawa
Honoraria - Abbvie; Chugai Pharma; Eisai; MSD
Consulting or Advisory Role - Novocure; Roche
Research Funding - Chugai Pharma (Inst); MSD (Inst)
 
Roger Henriksson
No Relationships to Disclose
 
Warren P. Mason
Honoraria - Roche
Consulting or Advisory Role - Roche
 
Lauren E. Abrey
Employment - Roche
 
Timothy Francis Cloughesy
Consulting or Advisory Role - Abbvie; Agios; Amgen; Celgene; Celldex; cortice; CytRx Corporation; Lpath; Nektar; NewGen Therapeutics; Novartis; Novocure; Oxigene; proximagen; Roche/Genentech; Stemcycle; Tocagen; Upsher-Smith; VBL Therapeutics; wellcome trust